Praveen Ramakrishnan, MD, MS, discusses the evolving landscape of CAR T-cell therapy in diffuse large B-cell lymphoma.
Praveen Ramakrishnan, MD, MS
Advertisement
Articles by Praveen Ramakrishnan, MD, MS
Praveen Ramakrishnan, MD, MS, discusses the clinical implications of CAR T-cell therapy in large B-cell lymphoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
3
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
4
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
5